About the Authors
- Megan C. Hanna
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
- Christina Go
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Christine Roden
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Robert T. Jones
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Panisa Pochanard
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Ahmed Yasir Javed
-
Affiliation Boston Baskin Cancer Foundation, Baptist Cancer Center, Memphis, Tennessee, United States of America
- Awais Javed
-
Affiliation Boston Baskin Cancer Foundation, Baptist Cancer Center, Memphis, Tennessee, United States of America
- Chandrani Mondal
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Emanuele Palescandolo
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Paul Van Hummelen
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Charles Hatton
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America
- Adam J. Bass
-
Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
- Sung Min Chun
-
Affiliation Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
- Deuk Chae Na
-
Affiliation Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
- Tae-Im Kim
-
Affiliation Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
- Se Jin Jang
-
Affiliation Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea
- Raymond U. Osarogiagbon
-
Affiliation Boston Baskin Cancer Foundation, Baptist Cancer Center, Memphis, Tennessee, United States of America
- William C. Hahn
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
- Matthew Meyerson
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
- Levi A. Garraway
-
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
- Laura E. MacConaill
-
* E-mail: Laura_Macconaill@dfci.harvard.edu
Affiliations Center for Cancer Genome Discovery, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, United States of America, Broad Institute, Cambridge, Massachusetts, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: LM MM LAG WCH. Performed the experiments: CG CR RTJ PP CM EP PH SMC DCN SJJ TK MCH. Analyzed the data: LM MCH EP CH AB. Contributed reagents/materials/analysis tools: RUO AYJ AJ SMC DCN SJJ TK CH. Wrote the manuscript: MCH LM AB.